Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grand Shuyang Life Sciences (chengdu) Co., Ltd.

Clinical trials sponsored by Grand Shuyang Life Sciences (chengdu) Co., Ltd., explained in plain language.

Trials to join now! 1

New blood disorder treatment aims to boost platelets fast

Disease control Recruiting now

This study is testing a 5-day intravenous immunoglobulin (IVIG) treatment for adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing bleeding risk. The goal is to see if this treatment can safely and effectively raise …

Phase: PHASE3 • Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC